Breast metastasis from solid tumors is a rare event. Melanoma, lung cancer, soft tissue sarcoma and ovarian carcinoma are the most common primaries. Intramammary metastases do not show a unique clinical or radiological pattern. Yet, accurate diagnosis and differentiation from primary breast tumors is very important to choose the appropriate treatment strategy and to avoid unnecessary interventions (1).
breast showed an oval hypoechoic lesion with foci of calcification measuring 11x4.3 mm at 12 o'clock in zone C, which was reported to be likely a suspicious intramammary lymph node. US guided core needle biopsy from the breast lesion was performed. Microscopic examination ( Figure 3 ) revealed cores of lymphoid tissue showing infiltration by papillary structures covered by atypical epithelial cells showing mild degree of atypia and pleomorphism. IHC studies for WT1, Cytokeratin 7 (CK7) and ER showed positive reaction in atypical cells, while (Progesterone Receptor) PR, mammaglobin and P53 showed negative reaction in tumor cells. This supported the diagnosis of metastatic ovarian carcinoma. The patient was prepared for receiving second line neoadjuvant therapy. Informed consent was obtained from the patient reported in this study.
Discussion and Conclusion
Secondary tumors to the breast are rare. They account to 0.2-2% of all breast neoplasms. The most common primary sites are contralateral breast, melanoma, lung cancer and ovarian cancer. Diagnosis of intramammary metastasis is a diagnostic challenge as it may resemble primary breast tumors clinically, radiologically and even pathologically (2) (3) (4) (5) . Proper evaluation and accurate pathological examination is recommended to avoid the possibility of unneeded breast intervention (e.g., mastectomy) (4, 6-10). Most of intramammary metastasis present as palpable breast swellings. Only about 14% are discovered by radiological evaluation -such as our presented case. The majority of these tumors present as solitary masses but 8-25% present as multifocal or bilateral breast masses (3) There are no specific radiologic criteria for intramammary metastasis which may be misinterpreted as benign or malignant primary breast masses on ultrasound or mammography. The most common pattern of presentation after being incidentally discovered during breast radiological evaluation is the presence of well-defined, hypoechoic oval or rounded mass with regular margins that does not show microcalcifications, speculations or posterior shadowing. (1, 3, 5) Pathologically, there are no specific criteria for diagnosis of such cases, especially in the absence of well-known history of prior malignancy. Yet, common histologic findings could be identified such as the presence of peritumoral fibrous pseudo-capsule and the absence of in situ component (4) .
Incidence of intramammary metastasis from ovarian carcinoma is very rare. It constitutes about 0.03%-0.6% of all breast tumors. It usually occurs 2 years after the primary presentation -In our patient, it was discovered 8 months after the initial presentation-. The most common histologic subtype is ovarian serous carcinoma. Those patients usually present with advanced stage with heavy peritoneal infiltration -like the case presented in this report-. Eighty-five percent of ovarian serous tumors are limited to the peritoneal cavity. The liver, lung and pleura are the most common site for metastases followed by the spleen, central nervous system, bone and skin. Yet, breast metastasis from ovarian carcinoma is associated with poorer prognosis with reported short term survival after the incidence of metastasis (1, 7-9, 11).
Accurate analysis of clinical, radiological and pathological features is required to differentiate such patients from those with primary breast carcinoma associated with Krukenburg ovarian tumors due to overlapping of pathologic features. Histopathological classification of breast secondary tumors and the differentiation from primary breast neoplasms is not an easy job and is based on the interpretation of both morphological and IHC features. The majority of intramammary metastases are characterized by the presence of papillary clusters and solid areas with slit-like spaces. Those spaces are composed of cells showing marked nuclear atypia. The adjacent breast tissue shows no pathological changes or intraductal component. IHC plays a very important role in such scenarios especially WT-1, the Wilms tumor gene product -which shows nuclear expression in about 95% of serous papillary carcinomas and only in less than 10% of breast cancers-, Gross cystic disease fluid protein (GCDFP-15), Paired-box gene 8 (PAX8) and mesothelin, which is expressed in more than 90% of ovarian serous papillary carcinoma. However, it is weakly expressed in 3 to 14% of primary breast malignancies (4, 7, 9, 11, 12) It is to be noted that breast and epithelial ovarian cancers share some similar hereditary and risk factors which can explain the co-incidence of primary breast and ovarian cancers. That is why patients with epithelial ovarian cancer are usually subjected to thorough physical, radio-193 In conclusion, intramammary metastasis from ovarian cancer is a rare condition that carries a poor prognosis. Despite having no pathognomonic clinical or radiological characteristics, thorough analysis of clinical, radiological and pathological data is required so as not to miss the diagnosis.
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